Blockade of the Thrombin Receptor Protease-Activated Receptor-1 with a Small-Molecule Antagonist Prevents Thrombus Formation and Vascular Occlusion in Nonhuman Primates-Reference-Cited by-同舟云学术

Blockade of the Thrombin Receptor Protease-Activated Receptor-1 with a Small-Molecule Antagonist Prevents Thrombus Formation and Vascular Occlusion in Nonhuman Primates

Published:2003-02-01 Issue:2 Volume:304 Page:855-861
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Derian Claudia K.,Damiano Bruce P.,Addo Michael F.,Darrow Andrew L.,D'Andrea Michael R.,Nedelman Mark,Zhang Han-Cheng,Maryanoff Bruce E.,Andrade-Gordon Patricia

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference38 articles.

1. Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats.;Andrade-Gordon;J Pharmacol Exp Ther,2001

2. Thrombin in arterial thrombosis.;Badimon;Haemostasis,1994

3. Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin

4. Oral Contraceptives and Hormone Replacement Therapy Do Not Increase the Incidence of Arterial Thrombosis in a Nonhuman Primate Model

5. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial Thrombosis;Journal of Medicinal Chemistry;2024-02-22

2. Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands;International Journal of Molecular Sciences;2023-03-24

3. Basics of Antiplatelet and Anticoagulant Therapy for Cardiovascular Disease;Interventional Cardiology;2022-05-06

4. The PAR4 Platelet Thrombin Receptor Variant rs773902 does not Impact the Incidence of Thrombotic or Bleeding Events in a Healthy Older Population;Thrombosis and Haemostasis;2021-12-01

5. Which proteinase-activated receptor-1 antagonist is better?: Evaluation of vorapaxar and parmodulin-2 effects on human left internal mammary artery endothelial function;Life Sciences;2021-12